A Preview Of Nektar Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Nektar Therapeutics is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.20. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares are currently trading at $0.55 and have seen a decrease of 86.02% over the last 52-week period.
November 06, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nektar Therapeutics is expected to report an EPS of $-0.20 in its upcoming earnings report. The company's share price has seen significant decrease over the past year.
The company's share price has been on a downward trend over the past year, which could be a cause for concern for investors. Additionally, the company's earnings per share is expected to be negative, which could further impact the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100